NF1 and malignant peripheral nerve sheath tumor: A Phase I study (NCT03618381) is testing EGFR806-directed CAR-T cells in pediatric and young adult patients with relapsed or refractory EGFR-expressing solid tumors, including NF1-associated MPNST.